Search - tctmd.com

Displaying 101 - 120 of 124

Sort: Relevancy | Date

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Marco Barbanti

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Presenter: T. Tanawuttiwat

January 29, 2014

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation

Outcomes of Patients with Chronic Lung Disease and Severe Aortic Stenosis Treated with TAVR vs. Surgical Replacement or Standard Therapy

Presenter: D. Dvir

October 22, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

Presentation

Transcatheter vs. Surgical Aortic Valve Replacement in Severe Aortic Stenosis: Echo Parameters in Cohort A of the PARTNER Trial

Presenter: Rebecca T. Hahn

April 24, 2013

Presentation ACC 2013

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: Vinod H. Thourani

March 11, 2013

Presentation TCT 2013

Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis

Presenter: Sammy Elmariah, Jonathan Passeri, Irene Hueter, Ronan Margey, Ignacio Inglessis, Joshua Baker, Maureen Daher, Susheel Kodali, Praveen Mehrotra, Martin Leon, Lars Svensson, Arvind Agnihotri, Gus Vlahakes, Philippe Pibarot, Pamela Douglas, Igor Palacios

January 31, 2013

Presentation TCT 2013

One Year Outcomes following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients Over 75 Years ‘The Elderly Pilot Study’

Presenter: Alaide Chieffo, Gill Buchanan, Azeem Latib, Irene Franzoni, Matteo Montorfano, Francesco Maisano, Micaela Cioni, Filippo Figini, Eustachio Agricola, Giovanni La Canna, Remo Covello, Annalisa Franco, Chiara Gerli, Pietro Spagnolo, Ermelinda De Meo, Alessandro Durante, Angela Ferrari, Ottavio Alfieri, Antonio Colombo

January 31, 2013

Presentation TCT 2013

Is Transcatheter Aortic Valve Implantation A Cost-Effective Treatment in Patients Who Are Ineligible For Surgical Aortic Valve Replacement?

Presenter: Rachele Busca, James Eaton, Pascale Brasseur, Ruben L. J. Osnabrugge, Stuart Mealing

January 31, 2013

Presentation TCT 2013

Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith, Stephen Worthley, Robert Whitbourn, Paul Antonis, Joseph Montarello, Andrew Newcomb, Dominic Allocco, Keith Dawkins

January 31, 2013

Presentation

Cost-Effectiveness of TAVR vs. Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: M.R. Reynolds

November 08, 2012

Presentation TCT 2012

Sutureless Surgical Aortic Valve Replacement: Is There a Role in the TAVR Era?

Presenter: Vinod Thourani

October 24, 2012

Presentation TCT 2012

TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial

Presenter: Mathew Williams

October 23, 2012

Presentation TCT 2012

TCT-94. Outcomes of Patients with Severe Aortic Stenosis and Chronic Obstructive Pulmonary Disease Treated with Transcatheter Versus Surgical Aortic Valve Replacement Versus...

Presenter: Danny Dvir

October 23, 2012

Presentation TCT 2012

TCT-93. Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis

Presenter: Sammy Elmariah

October 23, 2012

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

Advertisement

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Outcomes of Patients with Chronic Lung Disease and Severe Aortic Stenosis Treated with TAVR vs. Surgical Replacement or Standard Therapy

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Transcatheter vs. Surgical Aortic Valve Replacement in Severe Aortic Stenosis: Echo Parameters in Cohort A of the PARTNER Trial

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis

One Year Outcomes following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients Over 75 Years ‘The Elderly Pilot Study’

Is Transcatheter Aortic Valve Implantation A Cost-Effective Treatment in Patients Who Are Ineligible For Surgical Aortic Valve Replacement?

Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Cost-Effectiveness of TAVR vs. Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Sutureless Surgical Aortic Valve Replacement: Is There a Role in the TAVR Era?

TCT-95. Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial

TCT-94. Outcomes of Patients with Severe Aortic Stenosis and Chronic Obstructive Pulmonary Disease Treated with Transcatheter Versus Surgical Aortic Valve Replacement Versus...

TCT-93. Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content